Aquilo Capital Management, LLC Bicycle Therapeutics PLC Transaction History

Aquilo Capital Management, LLC

  • $128 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$7.68 - $11.08 $5.89 Million - $8.5 Million
-767,026 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$6.74 - $12.01 $198,809 - $354,258
29,497 Added 4.0%
767,026 $8.74 Million
Q2 2019

Aug 14, 2019
BUY
$10.06 - $14.63 $7.42 Million - $10.8 Million
737,529 New
737,529 $7.42 Million

Others Institutions Holding BCYC

# of Institutions
99
Shares Held
30.6M
Call Options Held
85.5K
Put Options Held
11.6K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $600M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Aquilo Capital Management, LLC Portfolio

Follow Aquilo Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email